Universitätsklinikum Düsseldorf

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2019) Fasching P, Hartkopf AD, Gaß P, Häberle L, Akpolat-Basci L, Hein A, Volz B, et al. Journal article Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation (2019) Zeiser R, Beelen DW, Bethge W, Bornhäuser M, Bug G, Burchert A, Christopeit M, et al. Journal article Comprehensive Cancer Center (CCC) in Deutschland: Ergebnisse einer Befragung zu Empfehlungen für die Palliativmedizinische Lehre im Medizinstudium (2018) Berendt J, Steigleder T, Van Oorschot B, Villalobos M, Simon ST, Scherg A, Ostgathe C Journal article Geriatric Basics for the Neurohospitalist (2018) Heckmann JG, Kraus J, Lang C Journal article, Review article Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter (2018) Nef HM, Abdel-Wahab M, Achenbach S, Joner M, Levenson B, Mehilli J, Moellmann H, et al. Journal article, Review article Correction: Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter (2018) Nef HM, Abdel-Wahab M, Achenbach S, Joner M, Levenson B, Mehilli J, Moellmann H, et al. Journal article, Erratum Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study (2018) Schochter F, Rack B, Tzschaschel M, Polasik A, Andergassen U, Trapp E, Alunni-Fabbroni M, et al. Journal article Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women (2018) Dittrich R, Kliesch S, Schuering A, Balcerek M, Baston-Buest DM, Beck R, Beckmann M, et al. Journal article Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44) (2018) Untch M, Von Minckwitz G, Gerber B, Schem C, Rezai M, Fasching P, Tesch H, et al. Journal article Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial (2018) Hepp P, Fasching P, Beckmann M, Fehm T, Salmen J, Hagenbeck C, Jaeger B, et al. Journal article